عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
 
 
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

Drugs Public Price List 2016

Drugs Prices According to the Exchange Rate Issued on 9/12/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016   (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016  (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016 
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016 .
 
Drugs Prices According to the Exchange Rate Issued on 1/12/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016.
 
Drugs Prices According to the Exchange Rate Issued on 11/11/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016.
 
Drugs Prices According to the Exchange Rate Issued on 1/11/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016.
 
Drugs Prices According to the Exchange Rate Issued on 17/10/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016.
    1
    ...
    92
    93
    94
    95
    96
    97
    ...
    193
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
J07BC02 HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED BioTech Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 1ml/dose 0.5ml/dose Injectable suspension 2,257,655 L.L
J07BF03 POLIOMYELITIS VACCINE INACTIVATED B Poliomyelitis virus type 1 inactivated - 40D.U, Poliomyelitis virus type 2 inactivated - 8D.U, Poliomyelitis virus type 3 inactivated - 32D.U Injectable suspension 1,206,771 L.L
L03AB03 IMUKIN BioTech Interferon gamma - 100mcg/0.5ml 100mcg/0.5ml Injectable suspension 6,348,312 L.L
J07BK01 VARICELLA VACCINE LIVE BioTech Varicella-herpes zoster virus (Oka strain), grown in human diploid cells (SV-cell line), live attenuated - Injectable suspension 3,104,276 L.L
J07BM03 GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT B Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml Injectable suspension 14,139,396 L.L
J07CA02 TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactivé adsorbé) B Diphteria toxoid purified - ≥30IU, Tetanus toxoid purified - ≥40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg Injectable suspension 1,628,737 L.L
J07CA09 INFANRIX HEXA B Diphteria toxoid purified (Prefilled syringe) - ≥30IU/0.5ml, Tetanus toxoid purified (prefilled syringe) - ≥40IU/0.5ml, Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg/0.5ml, Poliomyelitis virus type 1 antigen (prefilled syringe) - 40D.U./0.5ml, Poliomyelitis virus type 2 antigen(prefilled syringe) - 8D.U./0.5ml, Poliomyelitis virus type 3 antigen (prefilled syringe) - 32D.U./0.5ml, HBs Antigen (prefilled syringe) - 10mcg/0.5ml, H. Influenza type b polysaccharide (Vial) - 10mcg/0.5ml Injectable suspension 4,230,416 L.L
J07CA09 HEXAXIM BioTech Diphteria Toxoid - ≥20IU/0.5ml, Tetanus toxoid - ≥40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg Injectable suspension 4,462,901 L.L
J07CA09 HEXASIIL VACCINE (DIPHTERIA, TETANUS, PERTUSSIS, HEPATITIS B, POLIO, HAEMOPHILUS INFLUENZA TYPE B) Diphteria Toxoid - ≥30IU/0.5ml, Tetanus toxoid - ≥40IU/0.5ml, Bordetella pertussis (Whole cell) - ≥4IU/0.5ml, Hepatitis B, surface antigen - 15mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, H. Influenza type b polysaccharide1 ,2 - 10mcg/0.5ml, 1 conjugated to tetanus protein - 19-33mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - ≤1.25mg Injectable suspension 3,594,779 L.L
J07CA11 DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE B Diphteria Toxoid1 - ≤25Lf (≥30IU)/0.5ml, Tetanus toxoid1 - ≥2.5Lf (≥40IU)/0.5ml, Bordetella pertussis (Whole cell) - ≤16OU (≥4.0IU)/0.5ml, HBs Antigen (r DNA)1 - ≥10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - ≤1.25mg , 2 conjugated to tetanos toxoid carrier protein - Injectable suspension 1,515,854 L.L
H02AB01 DIPROFOS B Betamethasone (dipropionate) - 5mg/ml, Betamethasone (sodium phosphate) - 2mg/ml Injectable suspension 446,156 L.L
H02AB04 DEPO MEDROL B Methylprednisolone acetate - 40mg/ml 40mg/ml Injectable suspension 182,763 L.L
H02AB04 DEPO MEDROL B Methylprednisolone acetate - 80mg/2ml 80mg/2ml Injectable suspension 365,525 L.L
H02AB08 TRIACORT G Triamcinolone acetonide - 40mg/ml 40mg/ml Injectable suspension 745,833 L.L
L02AE03 ZOLADEX LA B Goserelin (acetate) - 10.8mg 10.8mg Injectable suspension L.L
R07AA INFASURF B Calfactant - 210mg/6ml 35mg/ml Injectable suspension 40,596,749 L.L
R07AA INFASURF B Calfactant - 105mg/3ml 35mg/ml Injectable suspension 23,344,161 L.L
L01BC07 AZACITIDINE ARROW G Azacitidine - 25mg/ml 25mg/ml Injectable suspension 10,967,854 L.L
L01BC07 LEUZADA G Azacitidine - 100mg 100mg Injectable suspension 10,969,285 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 100mg 100mg Injectable suspension, prolonged release 19,068,992 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 75mg 75mg Injectable suspension, prolonged release 15,240,595 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 50mg 50mg Injectable suspension, prolonged release 9,661,754 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 150mg 150mg Injectable suspension, prolonged release 27,480,894 L.L
N05AX13 TREVICTA B Paliperidone - 175mg 175mg Injectable suspension, prolonged release 35,006,803 L.L
N05AX13 TREVICTA B Paliperidone - 263mg 263mg Injectable suspension, prolonged release 40,713,289 L.L
N05AX13 TREVICTA B Paliperidone - 350mg 350mg Injectable suspension, prolonged release 50,113,451 L.L
N05AX13 TREVICTA B Paliperidone - 525mg 525mg Injectable suspension, prolonged release 75,169,610 L.L
N05AX13 BYANNLI B Paliperidone - 1000mg 1000mg Injectable suspension, prolonged release 141,223,863 L.L
N05AX13 BYANNLI B Paliperidone - 700mg 700mg Injectable suspension, prolonged release 96,913,302 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 100mg 100mg Injectable suspension, prolonged release L.L
    1
    ...
    92
    93
    94
    95
    96
    97
    ...
    193
Sitemap
© Copyrights reserved to Ministry of Public Health 2026